Drawing for EUFAPLEX

USPTO serial 98299112

EUFAPLEX

Reviewed by CopyMark Law Group

Status 732Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
PAPALE, LISA ANNE
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 732: Status 732 means the third six-month extension to file a Statement of Use was granted. You are past the midpoint of available extension time — plan SOU filing carefully.

Need help with EUFAPLEX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $349*

Plus Government fees of $150

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

James C. Watson

James C. Watson Traskbritt, P.C.230 South 500 East, #300Salt Lake City, UT 84102United States

Goods and services

ClassDescriptionStatusFirst use
005Nutraceuticals for use as a dietary supplement; Nutraceuticals containing processed aronia for use as a dietary supplement; Food supplements; Food supplements consisting of amino acids, minerals and trace elements; Nutraceuticals containing processed vitamins for use as a dietary supplement; Nutraceuticals containing vegetable oils and fats for use as a dietary supplement; Nutraceuticals containing anthocyanin for use as a dietary supplement; Nutraceuticals containing plant extracts for use as a dietary supplement for use with prepared, frozen, dried and cooked fruits and vegetables; Nutraceuticals for use as a dietary supplement for therapeutic or medical purposes; Nutraceuticals containing dimethyl sulfone for use as a dietary supplement; Food supplements, namely, anti-oxidants; Enzyme dietary supplements; Dietetic foods adapted for medical purposes; Mineral food supplements; Mineral preparations for human and animal use, for medical purposes; Amino acids for medical purposes; Vitamin preparations; Nutritional supplements; Freeze-dried food adapted for medical purposes; Propolis dietary supplements; nutraceutical preparations for use as a dietary supplement; vitamin and mineral dietary supplements; dietary supplements; nutraceutical preparations for use as a dietary supplement for therapeutic or medical purposes; health food supplements for persons with special dietary requirements; health food supplements made principally of vitamins; health food supplements made principally of minerals; health supplement food consisting primarily of omega-3 fatty acids; health supplement food consisting primarily of omega-6 fatty acids; health supplement food consisting primarily of omega-9 fatty acids; nutraceutical preparations in the nature of dietary supplements consisting primarily of omega-3 fatty acids; nutraceutical preparations in the nature of dietary supplements consisting primarily of omega-6 fatty acids; nutraceutical preparations in the nature of dietary supplements consisting primarily of omega-9 fatty acids; food supplements adapted for diabetics; vitamin and mineral food supplements; vitamins and vitamin preparations; vitamin drops and preparations; nutraceuticals in the nature of dietary supplements for therapeutic purposes; anti-oxidant food supplementsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 18, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 17, 2026EX3GSOU EXTENSION 3 GRANTED—
Jun 17, 2026EXT3SOU EXTENSION 3 FILED—
Jun 17, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 5, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 4, 2025EX2GSOU EXTENSION 2 GRANTED—
Nov 4, 2025EXT2SOU EXTENSION 2 FILED—
Nov 4, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 15, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 11, 2025EX1GSOU EXTENSION 1 GRANTED—
Jun 11, 2025EXT1SOU EXTENSION 1 FILED—
Jun 11, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 24, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 12, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 12, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 23, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 1, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 24, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 24, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 24, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 11, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 11, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 11, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 3, 2024DOCKASSIGNED TO EXAMINER—
Feb 29, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 5, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance